The Phytostilbene Resveratrol Induces Apoptosis in INS-1E Rat Insulinoma Cells

被引:13
作者
Bortolotti, Cornelia [1 ]
Kunit, Thomas [1 ]
Moder, Angelika [1 ]
Hufnagl, Clemens [1 ]
Schmidt, Sabine [1 ]
Hartl, Arnulf [1 ]
Langelueddecke, Christian [1 ]
Fuerst, Johannes [2 ]
Geibel, John P. [3 ,4 ]
Ritter, Markus [1 ]
Jakab, Martin [1 ]
机构
[1] Paracelsus Med Univ Salzburg, Inst Physiol & Pathophysiol, A-5020 Salzburg, Austria
[2] Innsbruck Med Univ, Dept Physiol & Med Phys, Div Physiol, Innsbruck, Austria
[3] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA
基金
奥地利科学基金会;
关键词
Resveratrol; Beta-cell; Insulin; Proliferation; Apoptosis; Akt; Caspase; PANCREATIC BETA-CELL; ACTIVATED PROTEIN-KINASE; CHEMOPREVENTIVE AGENT; GLIOMA-CELLS; CANCER; GROWTH; SURVIVAL; DEATH; INHIBITION; SECRETION;
D O I
10.1159/000218171
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
We investigated the effect of resveratrol on proliferation and induction of apoptosis of INS-1E rat insulinoma cells by cell counting, crystal violet staining, flow cytometry and immunoblotting. Resveratrol treatment of INS-1E cells at concentrations >= 50 mu M resulted in a dose-dependent inhibition of cell proliferation, accumulation of the cells in the S and G0/G1 phase and a significant increase of the percentage of apoptotic cells. This was paralleled by an increase of cell granularity, apoptotic volume decrease (AVD), exposure of phosphatidylserine at the outer leaflet of the plasma membrane, an increase of the 7-AAD signal and caspase activation. The AMP-kinase (AMPK) inhibitor compound C (10 mu M) significantly inhibited cell proliferation and induced caspase activation within 48 hours but this effect was not modified by resveratrol suggesting that AMPK is not a major target involved in mediating the proapoptotic effect of resveratrol in INS-1E cells. Immunoblotting revealed a significant inhibition of Akt (PKB) phosphorylation by 100 mu M resveratrol within 1 hour. Addition of insulin (10 mu M) to the culture medium strongly enhanced basal Akt phosphorylation. This enhancement was significantly attenuated by 50 and 100 mu M resveratrol. We conclude that the antiproliferative/proapoptotic effect of resveratrol on INS-1E cells is due to negative interference with Akt signaling and most likely disruption of auto/paracrine insulin signaling. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:245 / 254
页数:10
相关论文
共 50 条
[1]
IGF-1 protects against dexamethasone-induced cell death in insulin secreting INS-1 cells independent of AKT/PKB phosphorylation [J].
Avram, Diana ;
Ranta, Felicia ;
Hennige, Anita M. ;
Berchtold, Susanne ;
Hopp, Sabine ;
Haering, Hans-Ulrich ;
Lang, Florian ;
Ullrich, Susanne .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2008, 21 (5-6) :455-462
[2]
Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[3]
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt [J].
Chan, Anita Y. M. ;
Dolinsky, Vernon W. ;
Soltys, Carrie-Lynn M. ;
Viollet, Benoit ;
Baksh, Shairaz ;
Light, Peter E. ;
Dyck, Jason R. B. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (35) :24194-24201
[4]
CHANGCHEN KJ, 2008, REV ENDOCR METAB DIS
[5]
Caspases: the executioners of apoptosis [J].
Cohen, GM .
BIOCHEMICAL JOURNAL, 1997, 326 :1-16
[6]
Resveratrol stimulates AMP kinase activity in neurons [J].
Dasgupta, Biplab ;
Milbrandt, Jeffrey .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (17) :7217-7222
[7]
Resveratrol arrests the cell division cycle at S/G2 phase transition [J].
Della Ragione, F ;
Cucciolla, V ;
Borriello, A ;
Della Pietra, V ;
Racioppi, L ;
Soldati, G ;
Manna, C ;
Galletti, P ;
Zappia, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (01) :53-58
[8]
Resveratrol as a chemopreventive agent:: A promising molecule for fighting cancer [J].
Delmas, D ;
Lançon, A ;
Colin, D ;
Jannin, B ;
Latruffe, N .
CURRENT DRUG TARGETS, 2006, 7 (04) :423-442
[9]
Delmas D, 2000, ONCOL REP, V7, P847
[10]
Faber AC, 2006, INT J ONCOL, V29, P1561